WSJ
13 Oct 2026, 18:42 UTC · 1h ago
CVS Health Unit to Pay $315 Million to Resolve Illegal Opioid Prescription Claims
Impact · against what's priced in
The $315 million opioid settlement is a marginal negative catalyst that directly reduces net income for the current quarter. While the amount is small relative to overall cash flow, it slightly undermines the current guidance the market is relying on.
- CVS−0.15
Challenges what's priced in
- The price assumes
The raised full-year adjusted EPS guidance of $7.90–$8.10
The $315 million settlement charge is a one-time hit to net income that creates a headwind for the raised 2026 EPS guidance that the market is currently paying for.
What CVS's price assumes · Sep 9
Search tags
